Comparison of histologic and quantitative techniques in evaluation of therapy for experimental Pneumocystis carinii pneumonia.
about
Activities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumoniaTreatment of experimental pneumocystosis: review of 7 years of experience and development of a new system for classifying antimicrobial drugsFurazolidone and nitrofurantoin in the treatment of experimental Pneumocystis carinii pneumoniaCationic antitrypanosomal and other antimicrobial agents in the therapy of experimental Pneumocystis carinii pneumoniaGuanylhydrazones in therapy of Pneumocystis carinii pneumonia in immunosuppressed rats.Synergistic combinations of Ro 11-8958 and other dihydrofolate reductase inhibitors with sulfamethoxazole and dapsone for therapy of experimental pneumocystosisClinically used antimicrobial drugs against experimental pneumocystosis, singly and in combination: analysis of drug interactions and efficaciesImmunodeficient and immunosuppressed mice as models to test anti-Pneumocystis carinii drugsComplexity of the MSG gene family of Pneumocystis cariniiRegulation of surfactant phosphatidylcholine secretion from alveolar type II cells during Pneumocystis carinii pneumonia in the rat.Urokinase-type plasminogen activator in inflammatory cell recruitment and host defense against Pneumocystis carinii in mice.Adoptive transfer of lymphocytes sensitized to the major surface glycoprotein of Pneumocystis carinii confers protection in the ratOutbreaks of Pneumocystis carinii pneumonia in colonies of immunodeficient mice.Properties of the major antigens of rat and human Pneumocystis cariniiInhibitors of folic acid synthesis in the treatment of experimental Pneumocystis carinii pneumoniaThe biology of Pneumocystis carinii.New rat model of Pneumocystis pneumonia induced by anti-CD4(+) T-lymphocyte antibodies.Evidence for two genetic variants of Pneumocystis carinii coinfecting laboratory ratsSemiquantitative technique for estimating Pneumocystis carinii burden in the lung.Pneumocystis carinii karyotypes.Comparative study of antipneumocystis agents in rats by using a Pneumocystis carinii-specific DNA probe to quantitate infectionActive immunization against Pneumocystis carinii with p55-v3 DNA vaccine in rats.Use of semiquantitative PCR to assess onset and treatment of Pneumocystis carinii infection in rat model.Alterations in cysteine proteinase content of rat lung associated with development of Pneumocystis carinii infection.Quantification and assessment of viability of Pneumocystis carinii organisms by flow cytometry.A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes.Molecular genetic distinction of Pneumocystis carinii from rats and humans.Serial indium-111-labelled IgG biodistribution in ratPneumocystis carinii pneumonia: a tool to monitor the course and severity of the infection
P2860
Q28316960-1029F448-8DA9-43EE-8D3D-6DF8D6F06F53Q28316964-DABF1CB0-7A3E-4331-BC59-25FC4BCD3DA3Q28335355-3D4A7D58-9F40-4194-8BD2-60F907735124Q28361037-11BEAF10-8636-449E-912C-3C05766BF765Q28368745-E1A40532-B4D7-4364-ABF6-264DF3C104DAQ28378586-954B6294-EF79-4123-82D9-A96C0CB26352Q28379455-12CF1A4C-5624-4CC2-95AF-EFEB7D06CD4EQ28379457-2F6044E5-72EA-49F6-A597-054D3E071C40Q33491775-BAD99417-9C3E-47DA-9B20-506FBC1D38D2Q33909879-431A7710-A649-4C39-A131-2C0B2F7E12CAQ34000389-C26FF711-8FF5-4B5D-8B65-D7C283586CDEQ34223487-5632265E-4385-4749-B8FE-04E3989EC932Q35088499-DE410B8B-A739-47B5-9BD9-8E1299B67C18Q35096026-9A183D65-942C-4E0D-A9FA-691788744FB4Q35289230-C81699DB-7E00-4B0D-8966-DEA231F3FD4FQ35949839-A2DE9CF8-F2F7-44C1-8267-D5084BA0A673Q36376539-9B2C81BF-EC81-40DC-ABED-334910D4470AQ37067989-2D4F88C7-0BA9-42D4-BE91-AD8418456770Q37185256-0881DC0D-8870-48A8-9869-7627CEEABAB1Q37187883-7F093252-116A-4CAB-8D10-E703938FB002Q37250058-4FE4F627-A0B3-4DA2-B751-EC85A4EC79DEQ39755819-19269488-B00C-4E35-B8E1-C8A5C0DE01D6Q40007141-FCCB514F-2703-4622-8953-012D1977EB3BQ40155580-A913DEC4-699C-4110-81CA-4F8260B485D1Q40211867-58E69663-A78D-475D-8A9D-839A8FCDD55DQ40347234-CAA313D1-EBBF-4A87-BB99-007978C8EC79Q42611949-0B71D41E-A8A5-4E87-8674-FF77013E9AAEQ57779880-EBF8B2B4-AC7E-40F6-B687-15B18E373525
P2860
Comparison of histologic and quantitative techniques in evaluation of therapy for experimental Pneumocystis carinii pneumonia.
description
1987 nî lūn-bûn
@nan
1987 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Comparison of histologic and q ...... neumocystis carinii pneumonia.
@ast
Comparison of histologic and q ...... neumocystis carinii pneumonia.
@en
type
label
Comparison of histologic and q ...... neumocystis carinii pneumonia.
@ast
Comparison of histologic and q ...... neumocystis carinii pneumonia.
@en
prefLabel
Comparison of histologic and q ...... neumocystis carinii pneumonia.
@ast
Comparison of histologic and q ...... neumocystis carinii pneumonia.
@en
P2093
P2860
P356
P1476
Comparison of histologic and q ...... neumocystis carinii pneumonia.
@en
P2093
D Stanforth
H L Hendrix
M T Cushion
P D Walzer
P2860
P304
P356
10.1128/AAC.31.2.197
P407
P577
1987-02-01T00:00:00Z